Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New light device eases mouth pain in lichen planus

NCT ID NCT05401201

Symptom relief Sponsor: Koite Health Oy Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a home-use light device and special mouth rinse to help people with oral lichen planus, a painful mouth condition. Thirteen participants used the device daily for a year alongside standard care. The goal was to see if it could reduce pain and inflammation better than standard treatment alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lumoral device and Lumorinse mouth rinse (dual-light antibacterial photodynamic therapy)
What this could lead to
If it works, this could provide a new at-home way to reduce pain and inflammation for people with oral lichen planus, possibly reducing the need for steroids.
What could go wrong
This was a very small study (13 people) with no control group, so results may not apply widely. The treatment is a device and mouth rinse, not a drug, so its effect may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

13 people

The number who actually took part.

Started

Feb 2023

Finished

Apr 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Histologically confirmed diagnosis of OLP with bilateral symmetrical lesions and gingival involvement * Able to provide a written consent * Willing and able to complete questionnaires * Able to co-operate with the treatment protocol and avoid any other oral hygiene measures outside of the study protocol Exclusion Criteria: * Lichenoid lesions suspected to be induced by contact allergy or drugs * Any treatment for OLP in two weeks prior to the study/ a history of topical therapy for OLP in the past 2 weeks or systemic therapy in the past 4 weeks; * Pregnant or lactating * Photosensitivity * Use of antibiotics within 2 weeks prior the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dental plaque are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Dental Plaque lichen planus, oral Plaque, Amyloid

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dental plaque Oral bacterial infection Oral lichen planus

Contacts and locations

Locations

  • Tampere University Hospital, Oral and maxillofacial diseases

    Tampere, Pirkanmaa, 33520, Finland

  • Wellbeing services County Pirkanmaa, Health Services, Orthodontics and specialized dental care

    Tampere, Pirkanmaa, 33520, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.